- Conditions
- Knee Osteoarthritis
- Interventions
- MCG, SCG
- Behavioral
- Lead sponsor
- Boston University Charles River Campus
- Other
- Eligibility
- 50 Years to 80 Years
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 73–96
of 244
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Osteoarthritis, Knee Osteoarthritis, Arthritis, Joint Diseases, Musculoskeletal Diseases, Rheumatic Diseases
- Interventions
- Exercise for Knee Osteoarthritis Recommendations (Control group), Exercise for Knee Osteoarthritis -(LBPP supported low-load treadmill Walking), Exercise for Knee Osteoarthritis - (Aquatic Walking)
- Other
- Lead sponsor
- Shirley Ryan AbilityLab
- Other
- Eligibility
- 50 Years to 75 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Osteoarthritis (OA) of the Knee
- Interventions
- Neural Ice, Triamcinolone acetate
- Device · Drug
- Lead sponsor
- Brixton Biosciences, Inc.
- Industry
- Eligibility
- 22 Years to 80 Years
- Enrollment
- 263 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 15
- States / cities
- Larkspur, California • Washington D.C., District of Columbia • Gainesville, Florida + 12 more
- Conditions
- Osteoarthritis, Knee
- Interventions
- mHACMb, placebo
- Drug · Other
- Lead sponsor
- Applied Biologics, LLC
- Industry
- Eligibility
- 30 Years and older
- Enrollment
- 320 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Home-based exercise and weight management program
- Behavioral
- Lead sponsor
- Dartmouth-Hitchcock Medical Center
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2027 – 2029
- U.S. locations
- 1
- States / cities
- Lebanon, New Hampshire
- Conditions
- Osteo Arthritis Knee
- Interventions
- Geniculate Artery Embolization, Sham Procedure
- Device · Diagnostic Test
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 2
- States / cities
- Chapel Hill, North Carolina • Woodbridge, Virginia
- Conditions
- Osteoarthritis of the Knee
- Interventions
- TV-45070, Placebo
- Drug
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Eligibility
- 40 Years to 85 Years
- Enrollment
- 389 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 42
- States / cities
- Anaheim, California • Cerritos, California • El Cajon, California + 35 more
- Conditions
- Osteoarthritis
- Interventions
- tanezumab 10 mg, tanezumab 5 mg, naproxen, placebo
- Biological · Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 849 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 95
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 69 more
- Conditions
- Degenerative Osteoarthritis
- Interventions
- TG-C, Placebo Control
- Biological
- Lead sponsor
- Kolon TissueGene, Inc.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 531 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 27
- States / cities
- Tucson, Arizona • Anaheim, California • Beverly Hills, California + 23 more
- Conditions
- Knee Osteoarthritis
- Interventions
- Lavage with Platelet Poor Plasma (PPP)
- Biological
- Lead sponsor
- Regenexx, LLC
- Industry
- Eligibility
- 35 Years to 85 Years
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Broomfield, Colorado
- Conditions
- Knee Osteoarthritis
- Interventions
- Vivo Online Exercise Program, Medbridge Home program
- Other
- Lead sponsor
- Intermountain Health Care, Inc.
- Other
- Eligibility
- 55 Years to 85 Years
- Enrollment
- 334 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Murray, Utah
- Conditions
- Osteoarthritis, Knee, Osteoarthritis, Hip
- Interventions
- Not listed
- Lead sponsor
- Memorial Bone and Joint Research Foundation
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 990 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2030
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Hip Osteoarthritis
- Interventions
- Platelet Rich Plasma Joint Injection, Corticosteroid Injection
- Device · Drug
- Lead sponsor
- LifeBridge Health
- Other
- Eligibility
- 21 Years to 80 Years
- Enrollment
- 54 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Knee Osteoarthritis, Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA)
- Interventions
- Registry (N/A)
- Other
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Osteoarthritis
- Interventions
- Synvisc
- Device
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 2
- States / cities
- Chicago, Illinois • Evanston, Illinois
- Conditions
- Knee Osteoarthritis
- Interventions
- High Frequency TENS, Low frequency TENS, Placebo TENS
- Procedure
- Lead sponsor
- University of Iowa
- Other
- Eligibility
- 30 Years to 95 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Hip Osteoarthritis
- Interventions
- PRP, Hyaluronic Acid
- Biological · Device
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 30 Years to 72 Years
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2019
- U.S. locations
- 1
- States / cities
- Boulder, Colorado
- Conditions
- Osteoarthritis, Pain
- Interventions
- Placebo, Fulranumab 1 mg, Fulranumab 3 mg
- Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Costa Mesa, California • Laguna Hills, California + 23 more
- Conditions
- Osteoarthritis
- Interventions
- tanezumab 10 mg, tanezumab 5 mg, oxycodone, placebo
- Biological · Drug · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 66
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 54 more
- Conditions
- Knee Osteoarthritis (OA)
- Interventions
- Participants are given Ibuprofen 400 mg to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times., Participants are given a placebo to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times.
- Drug
- Lead sponsor
- David Grant U.S. Air Force Medical Center
- Federal
- Eligibility
- 45 Years to 75 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Travis AFB, California
- Conditions
- Osteoarthritis, Knee
- Interventions
- Capsaicin Topical Solution, Drug product vehicle
- Drug · Other
- Lead sponsor
- Propella Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 3
- States / cities
- Clearwater, Florida • Tampa, Florida • Dallas, Texas
- Conditions
- Osteoarthritis
- Interventions
- sodium hyaluronate, placebo
- Device
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 79 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 1
- States / cities
- St. Petersburg, Florida
- Conditions
- Osteoarthritis
- Interventions
- High molecular weight hylan (Synvisc) injection
- Procedure
- Lead sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- NIH
- Eligibility
- Not listed
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Knee Osteoarthritis
- Interventions
- Hymovis Intra-articular Injection, Phosphate Buffered Saline Injection
- Device · Procedure
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Encinitas, California + 28 more